6:11 PM ET
Earnings Call
▶ Call
Nuvation Bio Earnings Call: Key Takeaways
Nuvation Bio reported strong Iptrosi growth despite a 15% market-wide decline in ROS1 TKI starts, while advancing its IDH1 mutant glioma program toward 2027 data readouts.
- Call
- Nov 4, 2026, 4:30 PM ET